A Study Evaluating the Safety and Pharmacokinetics of ABBV-744 in Participants With Relapsed/Refractory Acute Myeloid Leukemia (AML) Cancer
Clinical trial NCT03360006 · TERMINATED
Trial details
- NCT number
- NCT03360006
- Sponsor
- AbbVie
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-16
- Primary completion
- 2020-12-19
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.